What Interventions are Cost Effective in Reducing Violence Against Women? A Scoping Review

被引:2
作者
Sheppard, Lauren [1 ]
Alsubhi, Moosa [1 ]
Brown, Vicki [1 ]
Le, Ha [1 ]
Robinson, Kim [2 ]
Moodie, Marj [1 ]
机构
[1] Deakin Univ, Inst Hlth Transformat, Fac Hlth, Sch Hlth & Social Dev,Deakin Hlth Econ, Geelong, Vic 3220, Australia
[2] Deakin Univ, Fac Hlth, Sch Hlth & Social Dev, Geelong, Vic 3220, Australia
关键词
INTIMATE PARTNER VIOLENCE; INVESTMENT; PREVENTION; GUIDELINES; RETURN; CARE;
D O I
10.1007/s40258-023-00870-0
中图分类号
F [经济];
学科分类号
02 ;
摘要
PurposeTo systematically summarise the recent literature on the cost and cost effectiveness of interventions implemented to reduce violence against women (VAW) and decision frameworks guiding resource allocation.MethodA scoping review of scholarly and grey literature on the cost-effectiveness and/or resource allocation for interventions addressing intimate partner violence (IPV), dating violence and non-partner sexual violence perpetrated against women aged 15 years and over. All settings and contexts were eligible, with papers published in English between 2010 and March 2023 included.ResultsNineteen papers fulfilled the inclusion criteria reporting the cost, cost savings and/or cost effectiveness of 24 interventions to prevent IPV and to a lesser extent, other forms of interpersonal violence. Among the 16 economic evaluation studies reviewed, four types of interventions were cost effective in multiple settings or studies, including community activism (Uganda, Ghana), gender transformative interventions with couples and individuals (Ethiopia, Rwanda), specific justice and law enforcement measures (USA) and a combined personnel training, support, and referral programme in General Practice in the UK. Other interventions were cost effective in a single study or had conflicting evidence. Three remaining papers conducted a partial evaluation or cost appraisal providing limited information on the cost or cost-savings of other implemented interventions. No frameworks on resource allocation for the prevention of VAW were identified.ConclusionWhile there is some evidence of cost effectiveness emerging for interventions implemented in specific contexts, overall, we find the recent evidence on costs and cost effectiveness of interventions for the prevention of VAW to be limited. Embedding economic evaluation in future effectiveness trials will build critical evidence needed to inform policy and resource allocation decisions based on the value-for-money of interventions. Modelling the benefits and costs of interventions to better understand the societal impacts of programmes at scale is a further research opportunity.
引用
收藏
页码:283 / 296
页数:14
相关论文
共 47 条
  • [1] Academy of Managed Care Pharmacy, 2016, AMCP FORM FORM SUBM
  • [2] [Anonymous], 2021, Covidence systematic review software
  • [3] Baraki B, 2021, REFUGE SOCIAL RETURN
  • [4] Cost-effectiveness of a domestic violence and abuse training and support programme in primary care in the real world: updated modelling based on an MRC phase IV observational pragmatic implementation study
    Barbosa, Estela Capelas
    Verhoef, Talitha Irene
    Morris, Steve
    Solmi, Francesca
    Johnson, Medina
    Sohal, Alex
    El-Shogri, Farah
    Dowrick, Susanna
    Ronalds, Clare
    Griffiths, Chris
    Eldridge, Sandra
    Lewis, Natalia V.
    Devine, Angela
    Spencer, Anne
    Feder, Gene
    [J]. BMJ OPEN, 2018, 8 (08):
  • [5] Boxall H., 2020, Statistical Bulletin, V28, P1, DOI DOI 10.52922/SB04718
  • [6] Boxall H, 2021, RES REPORT
  • [7] Campbell and Cochrane Economics Methods Group (CCEMG) and the Evidence for Policy and Practice Information and Coordinating Centre (EPPI-Centre), 2019, COST CONVERTER V 1 6
  • [8] A Reporting Tool for Practice Guidelines in Health Care: The RIGHT Statement
    Chen, Yaolong
    Yang, Kehu
    Marusic, Ana
    Qaseem, Amir
    Meerpohl, Joerg J.
    Flottorp, Signe
    Akl, Elie A.
    Schunemann, Holger J.
    Chan, Edwin S. Y.
    Falck-Ytter, Yngve
    Ahmed, Faruque
    Barber, Sarah
    Chen, Chiehfeng
    Zhang, Mingming
    Xu, Bin
    Tian, Jinhui
    Song, Fujian
    Shang, Hongcai
    Tang, Kun
    Wang, Qi
    Norris, Susan L.
    [J]. ANNALS OF INTERNAL MEDICINE, 2017, 166 (02) : 128 - +
  • [9] Department of Health, 2016, GUID PREP SUBM PHARM
  • [10] Department of Health Department of Health, 2017, TECHNICAL GUIDELINES